Finally, Aβ(1–42) is but one neurotoxic peptide produced from APP proteolytic processing: other, non-Aβ peptides are produced, that is, sAPPα, Jcasp, and C31, each of which has been implicated in neurotoxicity or other components of the AD phenotype [64–67]. The gene discussed is APP; the disease is Alzheimer disease.